TGFB1 and Hepatic fibrosis: The primary components of Astragali radix, astragalosides, were found to significantly inhibit the progression of CCl4-induced hepatic fibrosis in vivo as well as inhibit the proliferation of TGF-β1-stimulated HSCs in vitro (20).